These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 31927768)

  • 41. Eye movement disorders are different in Parkin-linked and idiopathic early-onset PD.
    Machner B; Klein C; Sprenger A; Baumbach P; Pramstaller PP; Helmchen C; Heide W
    Neurology; 2010 Jul; 75(2):125-8. PubMed ID: 20625164
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cognitive profile of Parkinson's disease patients: a comparative study between early-onset and late-onset Parkinson's disease.
    Tang H; Huang J; Nie K; Gan R; Wang L; Zhao J; Huang Z; Zhang Y; Wang L
    Int J Neurosci; 2016; 126(3):227-34. PubMed ID: 26001202
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lack of association between cancer history and PARKIN genotype: a family based study in PARKIN/Parkinson's families.
    Alcalay RN; Clark LN; Marder KS; Bradley WE
    Genes Chromosomes Cancer; 2012 Dec; 51(12):1109-13. PubMed ID: 22927236
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genotypic and phenotypic characteristics of Dutch patients with early onset Parkinson's disease.
    Macedo MG; Verbaan D; Fang Y; van Rooden SM; Visser M; Anar B; Uras A; Groen JL; Rizzu P; van Hilten JJ; Heutink P
    Mov Disord; 2009 Jan; 24(2):196-203. PubMed ID: 18973254
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Behavioral phenotyping of Parkin-deficient mice: looking for early preclinical features of Parkinson's disease.
    Rial D; Castro AA; Machado N; Garção P; Gonçalves FQ; Silva HB; Tomé AR; Köfalvi A; Corti O; Raisman-Vozari R; Cunha RA; Prediger RD
    PLoS One; 2014; 9(12):e114216. PubMed ID: 25486126
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Task matters - challenging the motor system allows distinguishing unaffected Parkin mutation carriers from mutation-free controls.
    Prasuhn J; Borsche M; Hicks AA; Gögele M; Egger C; Kritzinger C; Pichler I; Castelo-Rueda MP; Langlott L; Kasten M; Mascalzoni D; Klein C; Pramstaller PP; Brüggemann N
    Parkinsonism Relat Disord; 2021 May; 86():101-104. PubMed ID: 33895538
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mitochondrial impairment observed in fibroblasts from South African Parkinson's disease patients with parkin mutations.
    van der Merwe C; Loos B; Swart C; Kinnear C; Henning F; van der Merwe L; Pillay K; Muller N; Zaharie D; Engelbrecht L; Carr J; Bardien S
    Biochem Biophys Res Commun; 2014 May; 447(2):334-40. PubMed ID: 24721425
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Responsiveness to distracting stimuli, though increased in Parkinson's disease, is decreased in asymptomatic PINK1 and Parkin mutation carriers.
    Verleger R; Hagenah J; Weiss M; Ewers T; Heberlein I; Pramstaller PP; Siebner HR; Klein C
    Neuropsychologia; 2010 Jan; 48(2):467-76. PubMed ID: 19822161
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical and demographic correlates of apathy in Parkinson's disease.
    Brown DS; Barrett MJ; Flanigan JL; Sperling SA
    J Neurol; 2019 Feb; 266(2):507-514. PubMed ID: 30604055
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High frequency of Parkin exon rearrangements in Mexican-mestizo patients with early-onset Parkinson's disease.
    Guerrero Camacho JL; Monroy Jaramillo N; Yescas Gómez P; Rodríguez Violante M; Boll Woehrlen C; Alonso Vilatela ME; López López M
    Mov Disord; 2012 Jul; 27(8):1047-51. PubMed ID: 22777964
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The clinical features of Parkinson's disease in patients with mutations and polymorphic variants of GBA gene].
    Senkevich KA; Miliukhina IV; Beletskaia MV; Gracheva EV; Kudrevatykh AV; Nikolaev MA; Emelyanov AK; Kopytova AE; Timofeeva AA; Yakimovskii AF; Pchelina SN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(10):81-86. PubMed ID: 29171494
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of an Arabic version of the non-motor symptoms scale in Parkinson's disease.
    Sellami L; Kacem I; Nasri A; Djebara MB; Sidhom Y; Gargouri A; Gouider R
    Neurol Sci; 2016 Jun; 37(6):963-8. PubMed ID: 26932938
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Structural analysis of the effects of mutations in Ubl domain of Parkin leading to Parkinson's disease.
    Biswas S; Roy R; Biswas R; Bagchi A
    Gene; 2020 Feb; 726():144186. PubMed ID: 31647998
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence of parkin gene mutations and variations in idiopathic Parkinson's disease.
    Sinha R; Racette B; Perlmutter JS; Parsian A
    Parkinsonism Relat Disord; 2005 Sep; 11(6):341-7. PubMed ID: 16019250
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association between early-onset Parkinson's disease and mutations in the parkin gene.
    Lücking CB; Dürr A; Bonifati V; Vaughan J; De Michele G; Gasser T; Harhangi BS; Meco G; Denèfle P; Wood NW; Agid Y; Brice A; ;
    N Engl J Med; 2000 May; 342(21):1560-7. PubMed ID: 10824074
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bilateral subthalamic stimulation in Parkin and PINK1 parkinsonism.
    Moro E; Volkmann J; König IR; Winkler S; Hiller A; Hassin-Baer S; Herzog J; Schnitzler A; Lohmann K; Pinsker MO; Voges J; Djarmatic A; Seibler P; Lozano AM; Rogaeva E; Lang AE; Deuschl G; Klein C
    Neurology; 2008 Apr; 70(14):1186-91. PubMed ID: 18378882
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Case-control study of the parkin gene in early-onset Parkinson disease.
    Clark LN; Afridi S; Karlins E; Wang Y; Mejia-Santana H; Harris J; Louis ED; Cote LJ; Andrews H; Fahn S; Waters C; Ford B; Frucht S; Ottman R; Marder K
    Arch Neurol; 2006 Apr; 63(4):548-52. PubMed ID: 16606767
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of 50 probands with early-onset Parkinson's disease for Parkin mutations.
    Hedrich K; Marder K; Harris J; Kann M; Lynch T; Meija-Santana H; Pramstaller PP; Schwinger E; Bressman SB; Fahn S; Klein C
    Neurology; 2002 Apr; 58(8):1239-46. PubMed ID: 11971093
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Olfaction in Parkin heterozygotes and compound heterozygotes: the CORE-PD study.
    Alcalay RN; Siderowf A; Ottman R; Caccappolo E; Mejia-Santana H; Tang MX; Rosado L; Louis E; Ruiz D; Waters C; Fahn S; Cote L; Frucht S; Ford B; Orbe-Reilly M; Ross B; Verbitsky M; Kisselev S; Comella C; Colcher A; Jennings D; Nance M; Bressman S; Scott WK; Tanner C; Mickel S; Rezak M; Novak KE; Friedman JH; Pfeiffer R; Marsh L; Hiner B; Clark LN; Marder K
    Neurology; 2011 Jan; 76(4):319-26. PubMed ID: 21205674
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Parkinson's disease in Ireland: clinical presentation and genetic heterogeneity in patients with parkin mutations.
    Wiley J; Lynch T; Lincoln S; Skipper L; Hulihan M; Gosal D; Bisceglio G; Kachergus J; Hardy J; Farrer MJ
    Mov Disord; 2004 Jun; 19(6):677-81. PubMed ID: 15197707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.